3Ghina G,William HK ,Michael BA,et al. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystid ovary syndrome. Fertil Steril ,2003 ,79 :562-566. 被引量：1
4Yildiz BO,Knochenhauer ES,Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab,2007, Oct 9. 被引量：1
5Lam PM,Johnson IR, Raine-Fenning NJ. Three dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Repn:M ,2007 ,Oct 18. 被引量：1
6Dunalf,A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev ,1997 ,18 ,774-800. 被引量：1
7Apridonidze T, Essah PA, Iuomo MJ,et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab,2004,90:1929-1945. 被引量：1
8Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome ,towards a rational approach//Dunaif A, Givens JR,Haseltine F, et al. Polycystic ovary syndrome. Boston: Blackwell scientific publications, 1992:377-384. 被引量：1
9The Rotterdann ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome(PCOS). Hum Reprod,2004, 19:41-47. 被引量：1
10Dunaif A. Insulin resistance and ovarian hyperandrogenism. Endocrinologist, 1992,2:248-260. 被引量：1
